Davidson Kempner Capital Management LP acquired a new position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 175,000 shares of the pharmacy operator’s stock, valued at approximately $13,701,000.

A number of other institutional investors have also recently made changes to their positions in WBA. Commonwealth Bank of Australia boosted its stake in shares of Walgreens Boots Alliance by 139.5% in the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after purchasing an additional 26,893 shares in the last quarter. IBM Retirement Fund boosted its stake in shares of Walgreens Boots Alliance by 88.1% in the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after purchasing an additional 10,729 shares in the last quarter. Andra AP fonden boosted its stake in shares of Walgreens Boots Alliance by 35.3% in the 2nd quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after purchasing an additional 15,200 shares in the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 5.4% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after purchasing an additional 154,995 shares in the last quarter. Finally, Birinyi Associates Inc. boosted its stake in shares of Walgreens Boots Alliance by 9.0% in the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares in the last quarter. Hedge funds and other institutional investors own 60.24% of the company’s stock.

WBA has been the topic of several recent research reports. Pivotal Research cut their target price on shares of Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a research report on Tuesday, October 24th. Loop Capital initiated coverage on shares of Walgreens Boots Alliance in a research report on Thursday, August 24th. They set a “buy” rating and a $95.00 target price on the stock. Needham & Company LLC reiterated a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, October 12th. Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research report on Monday. They set a “hold” rating and a $78.00 target price on the stock. Finally, BidaskClub downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus price target of $86.47.

Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $70.18 on Wednesday. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a fifty-two week low of $63.82 and a fifty-two week high of $88.00. The stock has a market cap of $70,879.76, a P/E ratio of 14.03, a price-to-earnings-growth ratio of 1.27 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The firm had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. During the same quarter last year, the business earned $1.07 EPS. The company’s revenue was up 5.3% compared to the same quarter last year. sell-side analysts forecast that Walgreens Boots Alliance Inc will post 5.55 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.28%. Walgreens Boots Alliance’s payout ratio is 42.33%.

Walgreens Boots Alliance announced that its board has authorized a stock repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Anthony Lederer acquired 20,000 shares of the stock in a transaction dated Thursday, October 26th. The stock was bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION NOTICE: “Davidson Kempner Capital Management LP Invests $13.70 Million in Walgreens Boots Alliance Inc (WBA) Stock” was originally published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://theolympiareport.com/2017/12/06/davidson-kempner-capital-management-lp-invests-13-70-million-in-walgreens-boots-alliance-inc-wba-stock.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.